Literature DB >> 4168416

Studies in myasthenia gravis. 2. The relation of some clinical and immunological data.

H J Oosterhuis, H van der Geld, T E Gfeltkamp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168416     DOI: 10.1016/0022-510x(67)90027-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  7 in total

1.  Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

Authors:  W M Behan; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

2.  Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis.

Authors:  H J Oosterhuis; J Bethlem; T E Feltkamp
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

3.  Antiglobulin consumption test with sera from patients with myasthenia gravis.

Authors:  J A Aarli; O Tönder
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

4.  Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.

Authors:  J W Moll; H Hooijkaas; B C van Goorbergh; L G Roos; S C Henzen-Logmans; C J Vecht
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

Review 5.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

Review 6.  Thymectomy in myasthenia gravis. A review.

Authors:  H J Oosterhuis
Journal:  Ital J Neurol Sci       Date:  1983-12

7.  Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis.

Authors:  A Komiyama; I Kamo; S Furukawa; S Akazawa; K Hirayama; E Satoyoshi
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.